EMEA (Europe, Middle East and Africa) Nonsteroidal Antiinflammatory Drugs Market Report 2017

December 2017 | 106 pages | ID: E799E01C308EN
QYResearch

Abstracts

In this report, the EMEA Nonsteroidal Antiinflammatory Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Nonsteroidal Antiinflammatory Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nonsteroidal Antiinflammatory Drugs market competition by top manufacturers/players, with Nonsteroidal Antiinflammatory Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi S.A.
• Novartis AG
• GlaxoSmithKline PLC
• Pfizer
• DOMESCO

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Oral
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Osteoarthritis
• Muscle Aches
• Backaches
• Dental Pain
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Nonsteroidal Antiinflammatory Drugs Market Report 2017

1 NONSTEROIDAL ANTIINFLAMMATORY DRUGS OVERVIEW

1.1 Product Overview and Scope of Nonsteroidal Antiinflammatory Drugs
1.2 Classification of Nonsteroidal Antiinflammatory Drugs
  1.2.1 EMEA Nonsteroidal Antiinflammatory Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Nonsteroidal Antiinflammatory Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Injection
1.3 EMEA Nonsteroidal Antiinflammatory Drugs Market by Application/End Users
  1.3.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Osteoarthritis
  1.3.3 Muscle Aches
  1.3.4 Backaches
  1.3.5 Dental Pain
  1.3.6 Others
1.4 EMEA Nonsteroidal Antiinflammatory Drugs Market by Region
  1.4.1 EMEA Nonsteroidal Antiinflammatory Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Nonsteroidal Antiinflammatory Drugs (2012-2022)
  1.5.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2022)

2 EMEA NONSTEROIDAL ANTIINFLAMMATORY DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Nonsteroidal Antiinflammatory Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Nonsteroidal Antiinflammatory Drugs Sale Price by Players (2012-2017)
2.2 EMEA Nonsteroidal Antiinflammatory Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Nonsteroidal Antiinflammatory Drugs Sale Price by Type (2012-2017)
2.3 EMEA Nonsteroidal Antiinflammatory Drugs (Volume) by Application
2.4 EMEA Nonsteroidal Antiinflammatory Drugs (Volume and Value) by Region
  2.4.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Nonsteroidal Antiinflammatory Drugs Sales Price by Region (2012-2017)

3 EUROPE NONSTEROIDAL ANTIINFLAMMATORY DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Nonsteroidal Antiinflammatory Drugs Sales and Value (2012-2017)
  3.1.1 Europe Nonsteroidal Antiinflammatory Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type
3.3 Europe Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Application
3.4 Europe Nonsteroidal Antiinflammatory Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Nonsteroidal Antiinflammatory Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NONSTEROIDAL ANTIINFLAMMATORY DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Nonsteroidal Antiinflammatory Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type
4.3 Middle East Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Application
4.4 Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)

5 AFRICA NONSTEROIDAL ANTIINFLAMMATORY DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Nonsteroidal Antiinflammatory Drugs Sales and Value (2012-2017)
  5.1.1 Africa Nonsteroidal Antiinflammatory Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type
5.3 Africa Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Application
5.4 Africa Nonsteroidal Antiinflammatory Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Nonsteroidal Antiinflammatory Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Nonsteroidal Antiinflammatory Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2017)

6 EMEA NONSTEROIDAL ANTIINFLAMMATORY DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Sanofi S.A.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis AG
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline PLC
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 DOMESCO
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Nonsteroidal Antiinflammatory Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 NONSTEROIDAL ANTIINFLAMMATORY DRUGS MANUFACTURING COST ANALYSIS

7.1 Nonsteroidal Antiinflammatory Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nonsteroidal Antiinflammatory Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nonsteroidal Antiinflammatory Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NONSTEROIDAL ANTIINFLAMMATORY DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Nonsteroidal Antiinflammatory Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Nonsteroidal Antiinflammatory Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Nonsteroidal Antiinflammatory Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nonsteroidal Antiinflammatory Drugs
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Injection Product Picture
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Nonsteroidal Antiinflammatory Drugs by Application in 2016
Figure Osteoarthritis Examples
Table Key Downstream Customer in Osteoarthritis
Figure Muscle Aches Examples
Table Key Downstream Customer in Muscle Aches
Figure Backaches Examples
Table Key Downstream Customer in Backaches
Figure Dental Pain Examples
Table Key Downstream Customer in Dental Pain
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Nonsteroidal Antiinflammatory Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales Share by Players (2012-2017)
Figure 2016 Nonsteroidal Antiinflammatory Drugs Sales Share by Players
Figure 2017 Nonsteroidal Antiinflammatory Drugs Sales Share by Players
Figure EMEA Nonsteroidal Antiinflammatory Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Nonsteroidal Antiinflammatory Drugs Revenue Share by Players
Table 2017 EMEA Nonsteroidal Antiinflammatory Drugs Revenue Share by Players
Table EMEA Nonsteroidal Antiinflammatory Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Nonsteroidal Antiinflammatory Drugs by Type (2012-2017)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nonsteroidal Antiinflammatory Drugs by Type in 2016
Table EMEA Nonsteroidal Antiinflammatory Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Nonsteroidal Antiinflammatory Drugs by Application (2012-2017)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2016
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Nonsteroidal Antiinflammatory Drugs by Region (2012-2017)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Market Share in 2016
Table EMEA Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Nonsteroidal Antiinflammatory Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Nonsteroidal Antiinflammatory Drugs by Region (2012-2017)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Revenue Market Share Regions in 2016
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2017)
Table Europe Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Nonsteroidal Antiinflammatory Drugs Market Share by Type (2012-2017)
Figure Europe Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2016
Table Europe Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Nonsteroidal Antiinflammatory Drugs Market Share by Application (2012-2017)
Figure Europe Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2016
Table Europe Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Countries in 2016
Table Europe Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries in 2016
Figure Germany Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Nonsteroidal Antiinflammatory Drugs Market Share by Type (2012-2017)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Market Share by Type (2012-2017)
Table Middle East Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Nonsteroidal Antiinflammatory Drugs Market Share by Applications (2012-2017)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2016
Table Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2012-2017)
Figure Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2012-2017)
Figure Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2016
Table Africa Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2012-2017)
Figure Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2012-2017)
Table Africa Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Countries in 2016
Table Africa Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Countries in 2016
Figure South Africa Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Basic Information List
Table Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Nonsteroidal Antiinflammatory Drugs Basic Information List
Table Novartis AG Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis AG Nonsteroidal Antiinflammatory Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Nonsteroidal Antiinflammatory Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Basic Information List
Table GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Nonsteroidal Antiinflammatory Drugs Basic Information List
Table Pfizer Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Nonsteroidal Antiinflammatory Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Nonsteroidal Antiinflammatory Drugs Revenue Market Share in EMEA (2012-2017)
Table DOMESCO Nonsteroidal Antiinflammatory Drugs Basic Information List
Table DOMESCO Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure DOMESCO Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure DOMESCO Nonsteroidal Antiinflammatory Drugs Sales Market Share in EMEA (2012-2017)
Figure DOMESCO Nonsteroidal Antiinflammatory Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonsteroidal Antiinflammatory Drugs
Figure Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs
Figure Nonsteroidal Antiinflammatory Drugs Industrial Chain Analysis
Table Raw Materials Sources of Nonsteroidal Antiinflammatory Drugs Major Manufacturers in 2016
Table Major Buyers of Nonsteroidal Antiinflammatory Drugs
Table Distributors/Traders List
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Nonsteroidal Antiinflammatory Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Nonsteroidal Antiinflammatory Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources